• News
  • SAN DIEGO
  • BioTech

BioMarin buys Zacharon in $10 million deal

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said Monday that it bought privately held biotechnology firm Zacharon Pharmaceuticals for $10 million.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!